ABIGAIL ORTA: Open Payments
NPI 1285374645 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,381 in 116 payments from 13 companies in 2025. Trend: 2023 $2,499 · 2024 $2,435 · 2025 $2,381
Food & beverage: $2,381
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 74 | $1,672 |
| Novartis Pharmaceuticals Corporation | 18 | $216 |
| PFIZER INC. | 5 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $89 |
| Merck Sharp & Dohme LLC | 4 | $72 |
| Actelion Pharmaceuticals US, Inc. | 2 | $58 |
| Esperion Therapeutics, Inc. | 3 | $52 |
| SCPHARMACEUTICALS INC. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: SYMPLICITY G3, ONYX FRONTIER, LEQVIO, ELIQUIS, Kerendia, VERQUVO, OPSUMIT, NEXLETOL.
Industry payments across FL — which companies pay providers there.
